Press release
Peptide Therapeutics Market Set to Surpass USD 64.3 Billion by 2031
CAGR: 6.8%
Current Market Size: USD 33.3 Billion
Forecast Growing Region: APAC
Largest Market: North America
Projection Time: 2022 - 2031
Base Year: 2021
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ซ๐ https://www.alliedmarketresearch.com/request-sample/11591
๐๐๐ฒ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐จ๐ง๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐ง๐ ๐ญ๐จ ๐ญ๐ก๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ ๐ญ๐ก๐ ๐ฉ๐๐ฉ๐ญ๐ข๐๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐๐:
Rising Prevalence of Chronic Diseases: Peptide therapeutics offered potential solutions for treating chronic conditions such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders.
Enhanced Drug Delivery: Advances in drug delivery technologies allowed for more effective administration and increased bioavailability of peptide-based drugs.
Personalized Medicine: Peptide therapeutics showed promise in personalized medicine approaches, as they could be designed to target specific genetic or molecular markers in individual patients.
Favorable Regulatory Environment: Regulatory agencies' support and approvals for peptide-based drugs facilitated their commercialization and market growth.
Biotechnology Innovation: Continuous research and development efforts in the biotechnology sector led to the discovery of novel peptide-based drugs with improved efficacy and safety profiles.
Increasing Investment in Research: Pharmaceutical companies and investors showed growing interest in the peptide therapeutics market, leading to increased funding for research and development.
Global Aging Population: The aging population worldwide drove the demand for better treatment options, promoting the development of peptide therapeutics for age-related conditions.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ 20% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ (309 ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ https://www.alliedmarketresearch.com/peptide-therapeutics-market/purchase-options
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ ๐ ๐จ๐ซ ๐๐ญ๐๐ค๐๐ก๐จ๐ฅ๐๐๐ซ๐ฌ
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the peptide therapeutics market analysis from 2021 to 2031 to identify the prevailing peptide therapeutics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the peptide therapeutics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global peptide therapeutics market trends, key players, market segments, application areas, and market growth strategies.
๐๐๐ฒ ๐๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐ฌ๐ญ๐ฎ๐๐ฒ
โข By application, the metabolic segment was the highest contributor to the peptide therapeutics industry in 2021.
โข By route of administration, the parenteral segment was the highest contributor to the peptide therapeutics industry in 2021.
โข Depending on distribution channel, the hospital pharmacies segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
โข Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
๐๐จ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ - https://www.alliedmarketresearch.com/purchase-enquiry/11591
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ -
โข Eli Lilly and Company
โข Amgen Inc.
โข Pfizer Inc.
โข Takeda Pharmaceutical Company Limited
โข Novo Nordisk A/S
โข Sanofi SA
โข Ever Neuro Pharma GmbH
โข Bausch Health
โข GlaxoSmithKline plc
โข Abbvie (Allergan)
๐๐ง๐จ๐ฐ ๐๐จ๐ซ๐- https://www.alliedmarketresearch.com/peptide-therapeutics-market-A11226
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐ข๐๐ ๐๐๐ข๐๐ง๐๐ ๐๐จ๐ฆ๐๐ข๐ง-
๐๐ฒ๐ฌ๐ญ๐๐ซ๐๐๐ญ๐จ๐ฆ๐ฒ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/hysterectomy-devices-market-A13324
๐๐๐ง๐ญ๐๐ฅ ๐๐จ๐ฎ๐ซ๐ข๐ฌ๐ฆ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/dental-tourism-market-A74545
๐๐ซ๐๐ณ๐ข๐ฅ ๐๐๐๐ข๐๐๐ฅ ๐๐๐ฌ๐ญ๐ก๐๐ญ๐ข๐ ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/brazil-medical-aesthetic-devices-market-A30085
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Set to Surpass USD 64.3 Billion by 2031 here
News-ID: 3140737 • Views: โฆ
More Releases from Allied Market Research
3D Printing Filament Market Comprehensive Growth Outlook and Trend Analysis, 202 โฆ
According to the report, the global 3D printing filament market was valued at $0.9 billion in 2023 and is projected to reach $2.3 billion by 2031, registering a CAGR of 12.8% from 2024 to 2031.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/3d-printing-filament-market-A11572
Key Growth Drivers:
The growth of the 3D printing filament market is fueled by continuous advancements in filament materials-such as carbon fiber-reinforced composites, metal-infused filaments, and high-performance engineering plastics. These innovationsโฆ
Wet Chemicals Market Detailed Analysis, Growth Trends, and Future Outlook 2025-2 โฆ
According to a recent report by Allied Market Research (AMR), the global wet chemicals market is poised for substantial growth, projected to reach a value of $5.9 billion by 2031, up from $3.2 billion in 2021. This comprehensive analysis explores market dynamics, growth drivers, and strategic initiatives while highlighting key opportunities across regions and industry segments.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A17425
The study delves into development trends, investment frameworks, andโฆ
Nonwoven Fabrics Market Outlook to 2033 Projected High CAGR and Growth Opportuni โฆ
A new report titled "Nonwoven Fabrics Market by Polymer Type (Polypropylene (PP), Polyethylene (PE), Polyethylene Terephthalate (PET), Wood Pulp, Rayon, and Others), Function (Disposables and Durables), Technology (Spunbond, Dry Laid, Air Laid, Wet Laid, Meltblown, and Others), and Application (Hygiene, Wipes, Medical, Filtration, Automotive, Building & Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033" has been released by Allied Market Research.
Key Highlights:
- Market Size (2023): $58.4 Billion
- Projectedโฆ
Utilities Asset Management Market Poised for 11.3% CAGR Growth, Key Players, Mar โฆ
According to the report published by Allied Market Research, the global utilities asset management market generated $4.3 billion in 2021, and is projected to reach $12.4 billion by 2031, growing at a CAGR of 11.3% from 2022 to 2031.
The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape.โฆ
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva โฆ
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growthโฆ
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis โฆ
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehensionโฆ
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
โข Global Peptide Cancer Drug Market Insight By Region & Indication
โข Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
โข Approved Peptide Cancer Drugs: > 30 Drugs
โข Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
โข Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
โข Insight On Peptide Cancer Drugs In Clinical Trials: >โฆ
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market โฆ
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence ofโฆ
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept โฆ
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the globalโฆ
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an establishedโฆ
